Home/Filings/4/0001628280-22-031725
4//SEC Filing

NEIL GARRY ARTHUR 4

Accession 0001628280-22-031725

CIK 0001534120other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:22 PM ET

Size

4.7 KB

Accession

0001628280-22-031725

Insider Transaction Report

Form 4
Period: 2022-12-09
NEIL GARRY ARTHUR
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-12-09$4.42/sh+2,083$9,2079,220 total
Footnotes (1)
  • [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001586785

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:22 PM ET
Size
4.7 KB